REGN-7257 is a humanized monoclonal antibody targeting IL2RG. REGN-7257 blocks the signal transduction induced by common gamma chain (gammac) cytokines via the IL2RG chain of the gammac cytokine receptor complex. REGN-7257 is applicable for research on immune-mediated diseases and T cell-mediated diseases[1][2]. Its corresponding isotype control is Human IgG4 kappa, Isotype Control (HY-P99003).
Molecular Weight:
(145.41 kDa)
Purity:
95.34
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
